Legal Opinion
Millennium Pharmaceuticals, Inc. v. Sandoz Inc.
Court of Appeals for the Federal Circuit
Decided July 17, 2017No. 2015-2066, 2016-1008, 2016-1009, 2016-1010, 2016-1109, 2016-1110, 2016-1283, 2016-1762PublishedCited by 14 opinions
1Opinion of the Court
NEWMAN, Circuit Judge.
Millennium Pharmaceuticals, Inc. is the exclusive licensee of U.S. Patent No. 6,713,446 (“the ’446 Patent”), issued March 30, 2004 and assigned to the United States. Millennium developed the patented product for treatment of oncology disease, particularly multiple myeloma and mantle cell lymphoma. The product has the brand name Velcade®. Appellees in Appeal Nos. 15-2066, 16-1008,16-1009, 16-1010, 16-1110, 16-1283, and 16-1762 (collectively, “San-doz”) all filed abbreviated new drug applications (“ANDAs”), admitting infringement and seeking to invalidate various claims of…
2Cases cited31 opinions
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Microsoft Corp. v. i4i Ltd. PartnershipSupreme Court of the United States · 2011
- Pfizer, Inc. v. Apotex, Inc.Court of Appeals for the Federal Circuit · 2007
- Eurand, Inc. v. Mylan Pharmaceuticals Inc.Court of Appeals for the Federal Circuit · 2012
26 more not listed; retrieve them via the Exa API.
3Cited by14 opinions
- Arctic Cat Inc. v. Bombardier Recreational Products Inc.Court of Appeals for the Federal Circuit · 2017
- Adapt Pharma Operations v. Teva Pharmaceuticals USA, Inc.Court of Appeals for the Federal Circuit · 2022
- Pernix Ir. Pain Dac v. Alvogen Malta Operations Ltd.District Court, D. Delaware · 2018
- Hospira, Inc. v. Amneal Pharm., LLCDistrict Court, D. Delaware · 2018
- Meridian Mfg., Inc. v. C&B Mfg., Inc.District Court, N.D. Iowa · 2018
9 more not listed; retrieve them via the Exa API.